Diego)

被引:20
作者
Dispenzieri, Angela [1 ]
Merlini, Gianipaolo [2 ]
Comenzo, Raymond L. [3 ]
机构
[1] Mayo Clin, Div Hematol, Dept Med, Rochester, MN 55905 USA
[2] Univ Pavia, Fondazione IRCCS Policlin San Matteo, Amyloidosis Ctr, Dept Biochem, I-27100 Pavia, Italy
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
关键词
D O I
10.1016/j.bbmt.2007.10.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:6 / 11
页数:6
相关论文
共 50 条
[1]   Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins [J].
Comenzo, RL ;
Zhou, P ;
Fleisher, M ;
Clark, B ;
Teruya-Feldstein, J .
BLOOD, 2006, 107 (09) :3489-3491
[2]   Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: One-year follow-up in five patients [J].
Comenzo, RL ;
Vosburgh, E ;
Simms, RW ;
Bergethon, P ;
Sarnacki, D ;
Finn, K ;
Dubrey, S ;
Faller, DV ;
Wright, DG ;
Falk, RH ;
Skinner, M .
BLOOD, 1996, 88 (07) :2801-2806
[3]  
Comenzo RL, 1998, BLOOD, V91, P3662
[4]   Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628 [J].
Dhodapkar, MV ;
Hussein, MA ;
Rasmussen, E ;
Solomon, A ;
Larson, RA ;
Crowley, JJ ;
Barlogie, B .
BLOOD, 2004, 104 (12) :3520-3526
[5]   Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis [J].
Dispenzieri, A ;
Lacy, MQ ;
Rajkumar, SV ;
Geyer, SM ;
Witzig, TE ;
Fonseca, R ;
Lust, JA ;
Greipp, PR ;
Kyle, RA ;
Gertz, MA .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2003, 10 (04) :257-261
[6]   Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation [J].
Dispenzieri, A ;
Lacy, MQ ;
Katzmann, JA ;
Rajkumar, SV ;
Abraham, RS ;
Hayman, SR ;
Kumar, SK ;
Clark, R ;
Kyle, RA ;
Litzow, MR ;
Inwards, DJ ;
Ansell, SM ;
Micallef, IM ;
Porrata, LF ;
Elliott, MA ;
Johnston, PB ;
Greipp, PR ;
Witzig, TE ;
Zeldenrust, SR ;
Russell, SJ ;
Gastineau, D ;
Gertz, MA .
BLOOD, 2006, 107 (08) :3378-3383
[7]   Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival [J].
Dispenzieri, A ;
Lacy, MQ ;
Kyle, RA ;
Therneau, TM ;
Larson, DR ;
Rajkumar, SV ;
Fonseca, R ;
Greipp, PR ;
Witzig, TE ;
Lust, JA ;
Gertz, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) :3350-3356
[8]   Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation [J].
Dispenzieri, A ;
Gertz, MA ;
Kyle, RA ;
Lacy, MQ ;
Burritt, MF ;
Therneau, TM ;
McConnell, JP ;
Litzow, MR ;
Gastineau, DA ;
Tefferi, A ;
Inwards, DJ ;
Micallef, IN ;
Ansell, SM ;
Porrata, LF ;
Elliott, MA ;
Hogan, WJ ;
Rajkumar, SV ;
Fonseca, R ;
Greipp, PR ;
Witzig, TE ;
Lust, JA ;
Zeldenrust, SR ;
Snow, DS ;
Hayman, SR ;
McGregor, CGA ;
Jaffe, AS .
BLOOD, 2004, 104 (06) :1881-1887
[9]   Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis [J].
Dispenzieri, A ;
Gertz, MA ;
Kyle, RA ;
Lacy, MQ ;
Burritt, MF ;
Therneau, TM ;
Greipp, PR ;
Witzig, TE ;
Lust, JA ;
Rajkumar, SV ;
Fonseca, R ;
Zeldenrust, SR ;
McGregor, CGA ;
Jaffe, AS .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) :3751-3757
[10]   Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study [J].
Dispenzieri, A ;
Kyle, RA ;
Lacy, MQ ;
Therneau, TM ;
Larson, DR ;
Plevak, MF ;
Rajkumar, SV ;
Fonseca, R ;
Greipp, PR ;
Witzig, TE ;
Lust, JA ;
Zeldenrust, SR ;
Snow, DS ;
Hayman, SR ;
Litzow, MR ;
Gastineau, DA ;
Tefferi, A ;
Inwards, DJ ;
Micallef, IN ;
Ansell, SM ;
Porrata, LF ;
Elliott, MA ;
Gertz, MA .
BLOOD, 2004, 103 (10) :3960-3963